Cefoxitin Powder, a broad-spectrum cephalosporin antibiotic, exhibits potent activity against anaerobic bacteria commonly found in infections. This antibiotic is particularly effective in treating intra-abdominal and pelvic infections.
Transitioning to its mechanism of action, Cefoxitin Powder works by binding to penicillin-binding proteins (PBPs), disrupting bacterial cell wall synthesis. This inhibits bacterial growth and promotes bacterial cell death, making it a valuable tool in combating infections.
In clinical settings, Cefoxitin Powder is administered intravenously or intramuscularly, depending on the severity of the infection and patient factors. It is well-tolerated by most patients, with common side effects including nausea, vomiting, and diarrhea.
Furthermore, stability and compatibility of Cefoxitin Powder with various intravenous fluids make it convenient for administration in hospital settings. Its use in combination therapy with other antibiotics is also common for synergistic effects against multidrug-resistant bacteria.
In summary, broad-spectrum activity of Cefoxitin Powder, efficacy against anaerobic bacteria, and role in surgical prophylaxis highlight its importance in clinical practice. Its versatility, coupled with low resistance rates and manageable side effects, make it a valuable asset in the fight against bacterial infections.
| Cat. Number | AS-2036 |
| CAS Number | 35607-66-0 |
| Molecular Weight | 427.45 gr/mol |
| Molecular Formula | C16H17N3O7S2 |
| Storage Temperature | +4 °C |
| Form and Color | Powder / White to off-white |
| Purity (HPLC) | ≥ 97.5% |
| Water Content | ≤ 5% |
